PICCO, AGNESE
 Distribuzione geografica
Continente #
EU - Europa 6.981
AS - Asia 760
NA - Nord America 626
Continente sconosciuto - Info sul continente non disponibili 121
SA - Sud America 57
AF - Africa 24
OC - Oceania 3
Totale 8.572
Nazione #
IT - Italia 6.836
US - Stati Uniti d'America 582
SG - Singapore 322
CN - Cina 175
VN - Vietnam 145
FR - Francia 63
BD - Bangladesh 35
BR - Brasile 34
FI - Finlandia 21
HK - Hong Kong 18
NL - Olanda 16
AR - Argentina 14
JP - Giappone 13
CA - Canada 12
DE - Germania 12
MX - Messico 10
ID - Indonesia 8
IQ - Iraq 8
GB - Regno Unito 7
IN - India 7
DZ - Algeria 5
IE - Irlanda 5
CH - Svizzera 4
JM - Giamaica 4
TN - Tunisia 4
ZA - Sudafrica 4
BB - Barbados 3
BE - Belgio 3
CR - Costa Rica 3
RU - Federazione Russa 3
SV - El Salvador 3
TW - Taiwan 3
UZ - Uzbekistan 3
AT - Austria 2
AU - Australia 2
CO - Colombia 2
EC - Ecuador 2
ET - Etiopia 2
KE - Kenya 2
LB - Libano 2
LC - Santa Lucia 2
MA - Marocco 2
MY - Malesia 2
PH - Filippine 2
PR - Porto Rico 2
PY - Paraguay 2
SA - Arabia Saudita 2
SE - Svezia 2
TH - Thailandia 2
UA - Ucraina 2
AZ - Azerbaigian 1
BO - Bolivia 1
BS - Bahamas 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ES - Italia 1
GF - Guiana Francese 1
GT - Guatemala 1
HN - Honduras 1
JO - Giordania 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
MM - Myanmar 1
MN - Mongolia 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PK - Pakistan 1
PL - Polonia 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SL - Sierra Leone 1
SN - Senegal 1
TR - Turchia 1
VE - Venezuela 1
ZW - Zimbabwe 1
Totale 8.452
Città #
Genova 3.971
Genoa 1.668
Rapallo 661
Vado Ligure 467
Singapore 159
San Jose 101
Ashburn 84
Ho Chi Minh City 55
Lauterbourg 50
Beijing 41
Hanoi 27
Helsinki 20
Santa Clara 18
Bordighera 17
Hong Kong 15
New York 14
Council Bluffs 12
Oegstgeest 12
Frankfurt am Main 10
Tokyo 10
Rome 9
Da Nang 8
Chicago 6
Mexico City 6
Atlanta 5
Biên Hòa 5
Brooklyn 5
Dallas 5
Dublin 5
Haiphong 5
Los Angeles 5
Orem 5
Philadelphia 5
Tianjin 5
Washington 5
Cedar Rapids 4
Greenville 4
Houston 4
Phoenix 4
Zurich 4
Allen 3
Amsterdam 3
Chennai 3
Denver 3
Florence 3
Miami 3
Olympia 3
San José 3
Tashkent 3
Addis Ababa 2
Algiers 2
Allentown 2
Bologna 2
Boston 2
Brasília 2
Brussels 2
Buffalo 2
Burleson 2
Cantalupo Ligure 2
Cardiff 2
Castries 2
Chattanooga 2
Ciudad del Este 2
Cleveland 2
Columbus 2
Correggio 2
Dammam 2
El Paso 2
Erbil 2
Francavilla Fontana 2
Fredericksburg 2
Greensboro 2
Hammond 2
Helotes 2
Hixson 2
Huntsville 2
Hải Dương 2
Johannesburg 2
Litchfield Park 2
Mankato 2
Mendoza 2
Millington 2
Monterrey 2
Montreal 2
Nairobi 2
Naples 2
Ninh Bình 2
Norfolk 2
Old Orchard Beach 2
Orlando 2
Osasco 2
Oxnard 2
Paris 2
Passaic 2
Pittsburgh 2
Poplar 2
San Antonio 2
San Mateo 2
San Miguel 2
Schenectady 2
Totale 7.645
Nome #
A normative study of the Italian printed word version of the free and cued selective reminding test 234
Brain 18F-DOPA PET and cognition in de novo Parkinson's disease. 218
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project. 218
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort 214
Amyloid positron emission tomography and cognitive reserve. 204
Neuroimaging findings in mild cognitive impairment 204
Seizures can precede cognitive symptoms in late-onset Alzheimer's disease. 196
Brain dopaminergic (FluroDOPA PET) correlates of kinematic flexibility in Parkinson's Disease 195
Parkinson’s Disease Sleep Scale 2: application in an Italian population 192
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 183
Nigro-caudate dopaminergic deafferentation: A marker of REM sleep behavior disorder? 182
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD 177
Early identification of MCI converting to AD: a FDG PET study 176
18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage 176
Brain Functional Network in Alzheimer’s Disease: Diagnostic Markers for Diagnosis and Monitoring 174
Free water elimination improves test-retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects 171
Neuroimaging features in C9orf72 and TARDBP double mutation with FTD phenotype. 169
What predicts cognitive decline in de novo Parkinson's disease? 168
Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD 167
The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: An EADC study 161
Correlation between Doppler velocities and duplex ultrasound carotid cross-sectional percent stenosis. 158
Brain dopaminergic correlates of cognitive functions in de novo parkinson’s disease: a 18FDOPA PET study. 155
Frontal Variant Alzheimer Disease or Frontotemporal Lobe Degeneration With Incidental Amyloidosis? 154
Functional imaging in pre-motor Parkinson's disease 153
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes 153
Biomarkers validation in Alzheimer’s Disease and related pathologies 153
The role of the serotonergic system in REM sleep behavior disorder 151
Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. 150
Metabolic correlates of rey auditory verbal learning test in elderly subjects with memory complaints 149
Clinical validity of presynaptic dopaminergic imaging with (123)I-ioflupane and noradrenergic imaging with (123)I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development framework 146
Direct correlation between cardiac and striatal F-18-DOPA uptake in de novo Parkinson's disease 142
Screening of Early and Late Onset Alzheimer's Disease Genetic Risk Factors in a Cohort of Dementia Patients from Liguria, Italy. 142
Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study 142
Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework 139
Cortical structural covariance of nigro.striatal degeneration in dementia with Lewy bodies 138
Volume of interest-based [(18)F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. 136
Amygdalar nuclei and hippocampal subfields on MRI: test-retest reliability of automated volumetry across different MRI sites and vendors 133
What predicts future cognitive decline in de novo Parkinson’s disease (PD)? 132
Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study 132
Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework 131
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers 130
Performance of [18F] FDG-PET in 142 MCI patients with at least 2 years clinical follow up: a multicentric study of the European Alzheimer Disease Consortium (EADC) 125
Orbitofrontal (18) F-DOPA Uptake and Movement Preparation in Parkinson's Disease. 124
Dopaminergic Activity and Cognitive Function in de novo Parkinson Disease patients: an 18F-DOPA PET/CT study 123
Multisite longitudinal reliability of tract-based spatial statistics in diffusion tensor imaging of healthy elderly subjects 121
Neuroimaging Findings in Mild Cognitive Impairment 120
Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly 118
Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data 116
Test-retest reliability of the default mode network in a multi-centric fMRI study of healthy elderly: Effects of data-driven physiological noise correction techniques 111
Lupus nephritis and Cyclic Vomiting Syndrome: a case report. 110
Studio dell’attività serotoninergica troncoencefalica nel disturbo comportamentale del sonno REM. 102
Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease 102
Functional neuroimaging in de novo Parkinson's disease with REM sleep behaviour disorder 99
Nigrocaudate dopaminergic impairment predict future cognitive decline in de novo parkinson’s disease (PD) 97
Resting metabolic connectivity in Alzheimer's disease 87
White Matter Hyperintensities are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers 85
null 70
PSYCHOMETRIC PROPERTIES OF THE ITALIAN VERSION OF RESILIENCE SCALE IN ADULTS AND ELDERLY HEALTHY SUBJECTS 64
Totale 8.572
Categoria #
all - tutte 28.584
article - articoli 24.876
book - libri 0
conference - conferenze 2.142
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.117
Totale 56.719


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022703 23 20 52 81 23 67 31 167 50 62 22 105
2022/2023753 62 62 14 83 106 121 0 64 126 11 98 6
2023/2024422 20 42 8 59 39 88 18 37 19 5 19 68
2024/20251.130 35 79 18 78 162 131 107 169 54 48 109 140
2025/20261.974 287 46 93 140 293 165 312 83 196 163 98 98
2026/2027210 210 0 0 0 0 0 0 0 0 0 0 0
Totale 8.572